003000BSV in vitro assay for viral contaminants
Ended Awarded Last action
- Contract number
- HHSN261NUF57311
- Awardee
-
Bioreliance Corporation UEI H3KAG9A26K77
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $4,338
Award facts
- Contract value
-
- $4,338.00 Current, with exercised options
- $0.00 Potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Not on record Potential, with all options
- Funding agency
- Office of the Director National Institutes of Health, Department of Health and Human Services
- NAICS code
- Not on record
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 0 offers Simplified Acquisition
- Pricing
- Other
- Place of performance
- Bethesda, MD 20892, USA
Award details come from SAM.gov/FPDS.
Quick answers
Who was awarded contract HHSN261NUF57311?
HHSN261NUF57311 was awarded to Bioreliance Corporation by National Cancer Institute (National Institutes of Health) on December 26, 2006.
How much is contract HHSN261NUF57311 worth?
The government has obligated $4,338 on HHSN261NUF57311.
Which agency awarded contract HHSN261NUF57311?
National Cancer Institute (National Institutes of Health) awarded HHSN261NUF57311, with funding from Office of the Director (National Institutes of Health).
Is contract HHSN261NUF57311 an order under another contract?
Yes. HHSN261NUF57311 is a BPA call under HHSN263199800048997B, a blanket purchase agreement.
Was contract HHSN261NUF57311 competed?
The extent of competition for HHSN261NUF57311 was full and open competition. The government received 0 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award